Stay updated on Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.

Latest updates to the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedAdds MedlinePlus Genetics topic: Ovarian cancer and updates page revision to v3.0.2; removes the Back to Top link.SummaryDifference0.4%
- Check10 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of ovarian cancer related to MedlinePlus Genetics has been removed.SummaryDifference0.4%
- Check17 days agoChange DetectedThe web page has undergone significant changes, including the addition of specific drug information for Durvalumab and Toripalimab, as well as resources related to ovarian cancer. However, several key location details and previous drug classifications have been removed.SummaryDifference2%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Platform in Platinum-Resistant Ovarian Cancer Clinical Trial page.